sIL-2R is formed as the α chain of sIL-2R, and the expression of sIL-2R in tumor patients is increased, making the role of IL-2 blocked, and inducing T lymphocyte differentiation maturity gradually decreased. The gene discussed is IL2; the disease is neoplasm.